| Typicality: | 0.360 |
| Saliency: | 0.257 |
| in bladder cancer | 4 | location |
| in primary | 3 | location |
| telomerase → reverse → transcriptase promoter mutations | 8 |
| negative | neutral | positive |
| 0.338 | 0.641 | 0.021 |
| Raw frequency | 8 |
| Normalized frequency | 0.257 |
| Modifier score | 0.500 |
| Perplexity | 51.520 |